FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...